Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Rectum Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07419516
What this trial is testing

MRA Diameter as a Predictor for LLN Metastasis in Rectal Cancer.

Who this might be right for
Rectal Neoplasms
First Affiliated Hospital of Fujian Medical University 690
Not applicableStudy completedNCT04947020
What this trial is testing

DataBase for Analysis of Rectal Cancer Oncological Results

Who this might be right for
Rectal CancerMetforminOverall Survival+2 more
Jagiellonian University 2,443
Not applicableEnded earlyNCT03849950
What this trial is testing

Self-Management and Activation to Reduce Treatment-Related Toxicities (SMARTCare)

Who this might be right for
LymphomaLung CancerColo-rectal Cancer
University Health Network, Toronto 62
Large-scale testing (Phase 3)UnknownNCT01087268
What this trial is testing

Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer

Who this might be right for
Bladder CancerCervical CancerColorectal Cancer+9 more
Royal Marsden NHS Foundation Trust 75
Large-scale testing (Phase 3)Study completedNCT02314182
What this trial is testing

GRECCAR 8: Primary Tumor Resection in Rectal Cancer With Unresectable Metastasis

Who this might be right for
Rectal Adenocarcinoma
Hospices Civils de Lyon 5
Large-scale testing (Phase 3)Study completedNCT00079066
What this trial is testing

Cetuximab + Best Supportive Care Compared With Best Supportive Care Alone in Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer

Who this might be right for
Colorectal CancerQuality of Life
NCIC Clinical Trials Group 572
Not applicableLooking for participantsNCT04907643
What this trial is testing

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Who this might be right for
Cancer PainVisceral PainGastrointestinal Neoplasms+76 more
Cedars-Sinai Medical Center 360
Testing effectiveness (Phase 2)Looking for participantsNCT07011576
What this trial is testing

Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)

Who this might be right for
Colon CancerRectal CancerColorectal Cancer+1 more
SCRI Development Innovations, LLC 60
Testing effectiveness (Phase 2)Study completedNCT05480306
What this trial is testing

Phase 2 Study of DKN-01 in Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal AdenocarcinomaColo-rectal Cancer+1 more
Leap Therapeutics, Inc. 188
Testing effectiveness (Phase 2)Study completedNCT00030342
What this trial is testing

Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer

Who this might be right for
Colorectal CancerKidney Cancer
St. Luke's Medical Center 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT04616183
What this trial is testing

LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colon AdenocarcinomaMetastatic Colorectal CarcinomaMetastatic Rectal Adenocarcinoma+28 more
M.D. Anderson Cancer Center 46
Early research (Phase 1)Study completedNCT05130060
What this trial is testing

A Vaccine (PolyPEPI1018 Vaccine) and TAS-102 for the Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colon AdenocarcinomaMetastatic Colorectal AdenocarcinomaMetastatic Colorectal Carcinoma+8 more
Mayo Clinic 15
Early research (Phase 1)Ended earlyNCT00296062
What this trial is testing

Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer

Who this might be right for
Colorectal CancerUnspecified Adult Solid Tumor, Protocol Specific
Case Comprehensive Cancer Center 12
Not applicableStudy completedNCT02572362
What this trial is testing

Secondary Cancer Risk After Radiation Therapy for Rectal Cancer

Who this might be right for
Neoplasms, Second Primary
Kantonsspital Graubünden 25
Testing effectiveness (Phase 2)Study completedNCT00628810
What this trial is testing

Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Federation Francophone de Cancerologie Digestive 86
Testing effectiveness (Phase 2)Looking for participantsNCT07003022
What this trial is testing

Phase Ⅱ Clinical Trial of Cadonilimab Combined With Anti-angiogenic Agents in Metastatic dMMR/MSI-H CRC

Who this might be right for
Colo-rectal CancerMSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers
Fudan University 40
Not applicableStudy completedNCT00433602
What this trial is testing

Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
European Organisation for Research and Treatment of Cancer - EORTC 64
Large-scale testing (Phase 3)Study completedNCT00056446
What this trial is testing

Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsColonic NeoplasmsRectal Neoplasms
Novartis Pharmaceuticals 855
Testing effectiveness (Phase 2)Ended earlyNCT01198548
What this trial is testing

High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer

Who this might be right for
Stage IV Colon CancerStage IV Rectal Cancer
Roswell Park Cancer Institute 10
Early research (Phase 1)Study completedNCT00107250
What this trial is testing

AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)

Who this might be right for
Colorectal CancerLung CancerUnspecified Adult Solid Tumor, Protocol Specific
NCIC Clinical Trials Group 50
Next Page